Pharmaceutical manufacturing

People wearing face masks pass by a poster about precautions against the coronavirus as they visit to celebrate New Year at Imjingak in Paju, near the border with North Korea, South Korea, Friday, Jan. 1, 2021. The poster reads: "Precautions against the coronavirus." (AP Photo/Ahn Young-joon)
January 01, 2021 - 8:00 pm
SEOUL, South Korea — South Korea is extending stringent distancing rules for two more weeks as authorities seek to suppress a viral resurgence, while confirming its first case of an apparently more contagious coronavirus variant detected in South Africa. Health Minister Kwon Deok-cheol said...
Read More
FILE - This April 8, 2020, file photo shows a patient being evacuated from the Magnolia Rehabilitation and Nursing Center in Riverside, Calif. After months spent tamping down surges and keeping the coronavirus at manageable levels, a variety of factors combined to bring California to a crisis point in the pandemic. (AP Photo/Chris Carlson, File)
January 01, 2021 - 11:05 am
Here’s what’s happening Friday with the pandemic in the U.S.: THREE THINGS TO KNOW TODAY — After months of serving as a role model in the fight against COVID-19, California has seen infections race out of control for weeks. It now has the worst coronavirus diagnosis rate in the U.S. Experts say a...
Read More
FILE - In this March 16, 2020 file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. Tens of thousands of Americans have volunteered to test COVID-19 vaccines, but only about half of them got the real thing. Now, with the first vaccine rollouts and a surge in coronavirus infections, experts are debating what to do about the half that got a dummy shot. (AP Photo/Ted S. Warren, File)
January 01, 2021 - 5:42 am
Tens of thousands of Americans have volunteered to test COVID-19 vaccines, but only about half of them got the real thing during trials. Now, with the first vaccine rollouts and a surge in coronavirus infections, experts are debating what to do about the half that got a dummy shot. Should everyone...
Read More
Sri Lankan ethnic Tamil Hindu devotees decorate the entrance to their house in Colombo, Sri Lanka, Friday, Jan. 1, 2021. (AP Photo/Eranga Jayawardena)
January 01, 2021 - 1:27 am
BEIJING (AP) — Thailand's capital is shutting down venues including schools and entertainment areas as coronavirus cases continue to spread. Thailand reported 279 new cases on Friday including two deaths. Seven provinces including Bangkok have been designated red zones where places including...
Read More
People wait in a line in Sarasota, Fla., Thursday morning, Dec. 31, 2020, as COVID-19 vaccinations were made available to those over 65 and high-risk frontline health care workers. (Tom Stathis via AP)
December 31, 2020 - 7:27 pm
MIAMI — Florida health authorities late Thursday reported finding evidence of the latest U.S. case of the new and apparently more contagious coronavirus strain first seen in England, saying it was detected in a man with no recent travel history. The case, disclosed in a Florida Health Department...
Read More
Medical student Mara Karcher vaccinates a resident Ella Holdenried of Sankt Verena nursing home in Strassberg, Germany, Wednesday, Dec. 30, 2020. German authorities have reported more than 1,000 coronavirus-related deaths in one day for the first time since the pandemic began. The national disease control center, the Robert Koch Institute, said Wednesday that 1,129 more deaths were reported over the past 24 hours. (Felix Kaestle/dpa via AP)
December 31, 2020 - 11:15 am
THE HAGUE, Netherlands (AP) — The European Union medicines watchdog said Thursday that German company BioNTech has applied for clearance in the 27-nation bloc to administer up to six doses of its COVID-19 vaccine from each vial, instead of the five doses currently approved. In an email to The...
Read More
FILE - In this Dec. 25, 2020 file photo, released by Xinhua News Agency, a staff member inspects syringes of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm. The vaccine is the first one approved for general use in China.(Zhang Yuwei/Xinhua via AP, File)
December 31, 2020 - 5:15 am
BEIJING (AP) — China authorized its first homegrown COVID-19 vaccine for general use Thursday, adding another shot that could see wide use in poorer countries as the virus surges back around the globe. The Sinopharm vaccine had already been given to groups such as health care professionals and...
Read More
FILE - In this Dec. 30, 2020, file photo, an employee tolls the closing bell during a ceremony of the last trading day at the Tokyo Stock Exchange in Tokyo. Major Asian bourses were closed for the New Year's holidays Thursday, Dec. 31, while the handful that remained open was mixed. (JPX via AP)
December 30, 2020 - 7:11 pm
TOKYO (AP) — Major Asian bourses were closed for the New Year's holidays Thursday while the handful that remained open was mixed. Australia's S&P/ASX fell 0.8% to 6,632.10, while Hong Kong's Hang Seng gained 0.5% to 27,271.40. The Shanghai Composite gained 1.3% to 3,458.71. Trading was closed...
Read More
FILE - In this undated file photo issued by the University of Oxford, a researcher in a laboratory at the Jenner Institute in Oxford, England, works on the coronavirus vaccine developed by AstraZeneca and Oxford University. Britain on Wednesday, Dec. 30, authorized use of a second COVID-19 vaccine, becoming the first country to greenlight an easy-to-handle shot that its developers hope will become the “vaccine for the world.” The Department of Health said it had accepted a recommendation from the Medicines and Healthcare Products Regulatory Agency to authorize the vaccine developed by Oxford University and U.K.-based drugmaker AstraZeneca. (John Cairns/University of Oxford via AP, File)
December 30, 2020 - 11:04 am
LONDON (AP) — Britain became the first country to authorize AstraZeneca’s inexpensive, easy-to-handle COVID-19 vaccine Wednesday, gaining another weapon against the virus amid a resurgence so severe that the government extended lockdowns to three-quarters of England’s population. The country also...
Read More
In this photo Dec. 25, 2020 released by Xinhua News Agency, a staff member inspects syringes of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm in Beijing. The Chinese drugmaker said Wednesday, Dec. 30, 2020 its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries.(Zhang Yuwei/Xinhua via AP)
December 30, 2020 - 5:50 am
BEIJING (AP) — A Chinese drugmaker said Wednesday its coronavirus vaccine was found to be 79.3% effective at preventing infection in preliminary data from the final round of testing, moving Beijing closer to possibly being able to fulfill its pledge to supply other developing countries. The...
Read More

Pages